REGN vs RS · P/E 14, rev $14.34B vs P/E 26, rev $13.84B
Regeneron Pharmaceuticals Inc (REGN) versus Reliance Steel & Aluminum Co (RS) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Reliance Steel & Aluminum Co (RS) is a steel company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported RS revenue for 2024-12-31 was $13.84B. Net income was $878.0M. Revenue was down 6.6% from 2023-12-31 to 2024-12-31. RS currently screens at market cap $20.63B and trailing P/E 26.4.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. RS currently screens at market cap $20.63B and trailing P/E 26.4.
Not investment advice. Open the REGN and RS stock pages for the full models.
Not investment advice.